Gerontology Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Pharmacoepidemiol Drug Saf. 2010 Sep;19(9):942-8. doi: 10.1002/pds.1993.
The association between statin use and depression is complex, and research findings have been mixed. The present study aimed to investigate the association of statin use with depressive symptoms among community-living older persons, and its effect modifications by gender and medical co-morbidity.
Prospective observational study of 1803 participants aged 55 and above in the Singapore Longitudinal Ageing Studies cohort, with data of statin use and other risk factors for depression at baseline, and Geriatric Depression Scale (GDS) symptom scores at follow-up (1.5 years).
Controlling for baseline demographics, cholesterol level and medical co-morbidities, statin use was not associated with depressive symptom scores in the whole sample overall (regression coefficient = -0.12 (SE 0.10), F([1,1782]) = 1.44, p = 0.23). Post hoc analyses suggested that statin use may be associated with fewer depressive symptoms in women (p = 0.02), and more depressive symptoms in men, particularly those with more medical co-morbidities (p = 0.04) and multiple drug use (p = 0.02).
This study provided no strong evidence that support an overall association of statin use and depressive symptoms. The post hoc findings in this study are suggestive but may also be spurious and should be replicated in other studies.
他汀类药物的使用与抑郁之间的关系较为复杂,且研究结果并不一致。本研究旨在探究他汀类药物的使用与社区老年人群抑郁症状之间的关系,并分析其在性别和合并症方面的作用修饰效应。
这是一项前瞻性观察研究,共纳入了 1803 名年龄在 55 岁及以上的新加坡老龄化纵向研究队列参与者,在基线时收集了他汀类药物使用情况和其他抑郁危险因素的数据,并在随访(1.5 年)时使用老年抑郁量表(GDS)进行症状评分。
在控制基线人口统计学特征、胆固醇水平和合并症后,他汀类药物的使用与总体样本的抑郁症状评分无关(回归系数=-0.12(SE 0.10),F([1,1782])=1.44,p=0.23)。事后分析表明,他汀类药物的使用可能与女性的抑郁症状减少相关(p=0.02),与男性的抑郁症状增加相关,尤其是在合并症较多(p=0.04)和使用多种药物(p=0.02)的男性中。
本研究没有提供强有力的证据支持他汀类药物的使用与抑郁症状之间存在总体关联。本研究中的事后发现具有提示性,但也可能是虚假的,需要在其他研究中进行验证。